This inventor holds 26 USPTO granted patents and 16 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Laser Therapy. Top assignees: Erchonia Corporation, Erchonia Patent Holdings, LLC, Other. Active years: 2004-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mesa, AZ (US) (2004 - 2015)
- McKinney, TX (US) (2010 - 2015)
- Melbourne, FL (US) (2020 - 2023)
Company Filing History:
21 out of 26 
1 out of 3 
4 out of 834,513 Years Active: 2004-2023
Areas of Expertise:
Title: The Innovative Journey of Steven C. Shanks
Introduction
Steven C. Shanks, based in McKinney, Texas, is a notable inventor with an impressive portfolio of 26 patents. His work primarily focuses on advancements in light therapy, specifically in treating various neurological conditions. Shanks’ innovative approaches aim to enhance brain function and address challenges associated with autism and other nervous system disorders.
Latest Patents
Among Shanks’ latest patents are groundbreaking methods of treating the brain and nervous system using light therapy. This innovative approach involves applying light energy externally to the patient’s head and neck. This light energy stimulates various neurological pathways, reduces inflammation, enhances mitochondrial function in the brain, and increases heart rate variability (HRV). The treatment technique targets the vagus nerve and employs specific wavelengths of light, predominantly red light around 635 nm. Through the use of carefully selected pulse frequencies, such as 8 Hz, 53 Hz, 73 Hz, and 101 Hz, Shanks’ methods ensure that there is no detectable temperature rise in the treated tissue, making it a safe and non-invasive option.
Another significant patent by Shanks focuses on treating autism with light therapy. This method applies light to the patient's scalp, near the frontal and temporal lobes, while also potentially stimulating cranial nerves. The laser light, akin to his other patent, is administered from a hand-held device in a continuous, sweeping manner. The deliberate choice of red light around 635 nm and specific pulse frequencies enhances the therapy's efficacy.
Career Highlights
Throughout his career, Steven C. Shanks has contributed to innovative advancements in medical therapies, particularly through his association with Erchonia Corporation. His commitment to research and development has resulted in numerous patents that reflect his expertise in the use of light for therapeutic purposes.
Collaborations
Shanks has collaborated with various professionals, including notable coworkers Kevin B. Tucek and Ryan Maloney. These collaborations are essential in pushing the boundaries of current medical therapy and advancing the understanding of light's impact on neurological health.
Conclusion
Steven C. Shanks exemplifies the spirit of innovation within the realm of medical therapies. With his extensive patent portfolio and focus on light therapy applications, he continues to pave the way for new treatments in neuroscience. His work not only showcases the potential of non-invasive methods but also emphasizes the importance of interdisciplinary collaborations in achieving groundbreaking medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile